GlassScriptPhysician profile
Amanda L Powell
NPI 1104072990
$1,967.62
in general payments reported to CMS, 2019-2025
22 companies · $339 in 2025
The $339 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $536 · 2020: $89.54 · 2022: $267 · 2023: $475 · 2024: $261 · 2025: $339.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $902 · Education: $173.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $902.40 |
| Education | $172.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $306.53 | 2023-2024 | Veozah, Myrbetriq |
| Abbvie INC. | $256.93 | 2019-2025 | |
| Coopersurgical, INC. | $202.75 | 2019-2025 | Paragard T 380a |
| Pfizer INC. | $191.71 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $129.51 | 2019-2023 | Gardasil 9 |
| Daiichi Sankyo INC. | $125.49 | 2024-2025 | Injectafer |
| Intuitive Surgical, INC. | $119.34 | 2022 | |
| Mayne Pharma Commercial LLC | $84.05 | 2023-2025 | |
| Duchesnay USA Incorporated | $68.01 | 2019 | |
| Sumitomo Pharma America, INC. | $65.65 | 2025 | Myfembree, Gemtesa |
| Therapeuticsmd, INC. | $59.71 | 2019-2020 | |
| Millicent US INC | $53.95 | 2025 | Intrarosa, Femlyv, Femring |
| Organon LLC | $44.22 | 2025 | Nexplanon |
| Amag Pharmaceuticals, INC. | $42.21 | 2019 | |
| Applied Medical Resources Corporation | $39.64 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $36.39 | 2023 | Accrufer |
| Hologic Sales and Service, LLC | $35.85 | 2019-2025 | Aptima, Thinprep 2000 Processor |
| Exact Sciences Corporation | $31.38 | 2025 | The Cologuard Plus Collection Kit |
| Exeltis, USA INC. | $21.69 | 2023 | Slynd |
| Pharmacosmos Therapeutics INC. | $20.12 | 2024 | Monoferric |
| Ascendis Pharma Endocrinology INC | $16.81 | 2023 | |
| Allergan, INC. | $15.68 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Powell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.